ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
NamiRNA-Enhancer Network: The Changing Era Challenge and Chance of miRNA.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- MiRNAs in hyperglycemia-induced metabolic memory: established mechanisms and emerging nuclear activation concepts.Diabetology & metabolic syndrome · 2026Review
- Review
- The Multi-Target lncRNA-miRNA-mRNA TRIAD in Pancreatic Cancer Diagnosis and Therapy.International journal of molecular sciences · 2026Review
- Nanoparticle-Based miRNA Therapeutics in Breast Cancer Highlighting Design Strategies and Translational Potential.International journal of nanomedicine · 2026Review
- NamiRNA-Enhancer Network: The Changing Era Challenge and Chance of miRNA.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
MicroRNAs (miRNAs) systematically orchestrate multiple biological processes via gene regulation in various organisms. Conventionally, miRNAs bind to untranslated regions of mRNAs to modulate gene silencing in the cytoplasm. Recent studies have revealed that a subset of miRNAs located in the nucleus can efficiently activate gene transcription by targeting enhancers, named as Nuclear Activating miRNAs (NamiRNAs). The fundamental principle of this regulatory pattern is that NamiRNAs as "wedges" open double strands of genomic DNA and provide the prerequisite for RNA polymerase II-mediated transcription. Specifically, NamiRNAs bind to their target enhancers and form the hybrids of miRNAs and single-stranded DNA, which are recognized by Argonaute 2 (AGO2) to maintain the single-stranded state. Meanwhile, AGO2 protects these miRNA-DNA hybrids from RNase H-mediated degradation to maintain their stability. Additionally, NamiRNAs induce H3K27ac enrichment at target enhancers and put them into an active state conducive to gene activation. Notably, similar to NamiRNAs, Human Identical Sequences as exogenous small RNAs as critical pathogenic factors for RNA viruses, facilitate infectious disease progression. Collectively, this review systematically elucidates the theory of NamiRNA-Enhancer-mediated Gene Activation in combination with corresponding evidence, summarizes the functions and challenges of NamiRNAs, and discusses their potential in fundamental research and clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.